Skip to content

Opus Genetics IRD Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$46.14M-11.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$661.6M-21.8%
Regenxbio logo
RegenxbioRGNX
-$90.23M-1,589%
Prime Medicine logo
Prime MedicinePRME
-$49.21M+5.2%
uniQure logo
uniQureQURE
-$55.2M-23.6%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$129.69M+3.0%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's comprehensive income (loss), net of tax, attributable to parent?
Opus Genetics (IRD) reported comprehensive income (loss), net of tax, attributable to parent of -$65.54M in Q1 2026.
How has Opus Genetics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Opus Genetics's comprehensive income (loss), net of tax, attributable to parent decreased by 699.8% year-over-year, from -$8.19M to -$65.54M.
What is the long-term trend for Opus Genetics's comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), Opus Genetics's comprehensive income (loss), net of tax, attributable to parent has grown at a -3.3% compound annual growth rate (CAGR), from -$56.69M to -$49.59M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
The total of net income and other comprehensive income, representing the overall change in equity during the period from non-owner transactions. This metric offers a comprehensive view of the total financial performance and economic impact on shareholder value.